AI assistant
TherapeuticsMD, Inc. — Director's Dealing 2022
Dec 10, 2022
35134_dirs_2022-12-09_a05121d6-b5bb-465b-a5c8-a9b1d80ada28.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2022-12-06
Reporting Person: Walker Marlan D (General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-06 | Common Stock | M | 1010 | $0.00 | Acquired | 6189 | Direct |
| 2022-12-06 | Common Stock | M | 1156 | $0.00 | Acquired | 7345 | Direct |
| 2022-12-06 | Common Stock | M | 388 | $0.00 | Acquired | 7733 | Direct |
| 2022-12-06 | Common Stock | S | 1048 | $4.9475 | Disposed | 6685 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-06 | Restricted Stock Unit | $0.00 | M | 1010 | Disposed | Common Stock (1010) | Direct | |
| 2022-12-06 | Restricted Stock Unit | $0.00 | M | 1156 | Disposed | Common Stock (1156) | Direct | |
| 2022-12-06 | Restricted Stock Unit | $0.00 | M | 388 | Disposed | Common Stock (388) | Direct |
Footnotes
F1: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs).
F2: The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $4.66 through $5.41, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
F4: The RSUs vest in three equal installments annually, becoming fully vested on March 30, 2023.
F5: The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024.
F6: Subject to the reporting person's continuous service, the RSUs will vest in three equal installments annually, beginning September 29, 2022, becoming fully vested on September 29, 2024.